high-level resistance (minimal inhibitory concentration >2,000 ,uglml) to streptomycin and kanamycin, and resistance to penicillin-streptomycin and penicillinkanamycin synergism are transferable by conjugation from resistant clinical isolates of enterococci to a sensitive recipient strain. Cesium chloride-ethidium bromide ultracentrifugation revealed a satellite (plasmid) band in resistant clinical isolates and the transconjugant strains but not in the sensitive recipient. Examination of these satellite bands by agarose gel electrophoresis and electron microscopy demonstrated a common plasmid with a weight of 45 megadaltons.
A B S T R A C T Mating experiments have shown that
high-level resistance (minimal inhibitory concentration >2,000 ,uglml) to streptomycin and kanamycin, and resistance to penicillin-streptomycin and penicillinkanamycin synergism are transferable by conjugation from resistant clinical isolates of enterococci to a sensitive recipient strain. Cesium chloride-ethidium bromide ultracentrifugation revealed a satellite (plasmid) band in resistant clinical isolates and the transconjugant strains but not in the sensitive recipient. Examination of these satellite bands by agarose gel electrophoresis and electron microscopy demonstrated a common plasmid with a weight of 45 megadaltons.
Novobiocin treatment of a resistant clinical isolate produced simultaneous loss of high-level resistance to streptomycin and kanamycin, and of resistance to
INTRODUCTION
Enterococci are less susceptible to penicillin than other streptococci (minimal inhibitory concentration 4-8 vs. 0.03-0.12 U/ml) (1) , and enterococcal infections have historically been more resistant to treatment with single antimicrobial agents than infections with other streptococci. However, since the reports of Hunter in 1947 (2) , and Jawetz et al. in 1950 (3) , it has been known that combinations of penicillin and an aminoglycoside synergize to produce enhanced killing of' enterococci both in vitro (4) and in vivo (5) , and are significantly more effective than penicillin alone. Previous studies from this laboratory have suggested that synergism results from enhanced uptake of aminoglycosides into enterococci in the presence of' penicillin or other agents which inhibit bacterial cell wall synthesis (6) .
Synergistic therapy resulting from the use of penicillin and an aminoglycoside is now the basis for treatment of' serious human enterococcal infections. Therefore, we have been especially interested in the 25-50% of clinical isolates of enterococci with high-level resistance (minimal inhibitory concentration >2,000 ,ug/ml) to streptomycin and kanamycin which have now been reported from several cities, including Denver (7), Seattle (8) , Boston (9) , and London (10) . The resistance observed in these strains is f'ar above levels that are achievable in serum without producing unacceptable toxicity (20) (21) (22) (23) (24) (25) ,ug/ml f'or streptomycin and kanamycin). However, it is clinically relevant because strains with high-level aminoglycoside resistance are also resistant to antibiotic synergism with penicillin and that aminoglycoside (11) . The origin and nature of high-level aminoglycoside resistance and resistance to antibiotic synergism among clinical isolates of enterococci are presently unknown.
We undertook the studies reported here to determine if' the high-level aminoglycoside resistance observed among clinical isolates of enterococci was transferable, and if resistance to penicillin-aminoglycoside synergism was transferable simultaneously.
METHODS

Strains, media, and antibiotics
Resistant enterococei were selected as previously described (9) by screening enterococcal isolates from blood cultures of patients hospitalized at the Massachusetts General Hospital from 1968 to 1976. Before use in mating experiments, the presence of high-level resistance was verified by growth on brain heart infusion (BHI)' agar (1.5% agar) plates containing 2,000 ,ug/ml of aminoglycoside. Resistant strains grew on both streptomycin and kanamycin containing BHI plates. The sensitive recipient strain JH2-7 which required thymine (2 ,ug/ml) for growth in liquid media was kindly provided by Alan Jacob. This strain was resistant to fusidic acid and rifampin, but sensitive to aminoglycosides (minimal inhibitory concentration < 100 ,ug/ml for streptomycin and kanamycin) (12) . All enterococcal strains used in these studies, including the resistant clinical isolates, the sensitive recipient JH2-7, and transconjugant JH2-7 (pDRl) were Streptococcus faecalis strains, and were speciated according to standard criteria (13) .
We used BHI agar plates with either rifampin (100 gg/ml) or fusidic acid (25 ,ug/ml) to select for the recipient strain JH2-7; BHI agar with either streptomycin (2,000 ,ug/ml) or kanamycin (2,000 ,ug/ml) to select for the resistant clinical isolates; and combinations of rifampin and kanamycin (100 ,ug/ml and 1,000 ,ug/ml) or fusidic acid and streptomycin (25 ,ug 'Abbreviations used in this paper: BHI, brain heart infusion; TES, 50 mM Tris, 5 mM Na2EDTA, 50 mM NaCl, pH 8.0. Biochemical Corp., Freehold, N. J.) was dissolved in sterile distilled water (0.5 mg/ml). After preparation, aliquots of pronase, RNase A, and DNase I were frozen in small vials at -20°C, then thawed rapidly in a 370C water bath when needed and used only once.
Mating experiments
Single colonies of donor and recipient strains were inoculated into liquid BHI, and grown overnight. The following morning, 0.2 ml of overnight culture was inoculated into 20 ml of fresh liquid BHI and the cells were grown, with shaking, to mid-log phase. For mating 0.1-ml samples of donor and recipient cultures were added to 9.8 ml of liquid BHI. They were then incubated for 24 h with slow shaking. Control flasks for each experiment included donor and recipient cultures alone, and uninoculated BHI.
Presumed transconjugant strains from doubly selective media (either rifampin and kanamycin or fusidic acid and streptomycin) were plated again for single colonies on the same media, and then tested for all four resistance markers using a modified Steers replicator (14) . Only colonies bearing all four resistance markers were considered to be transconjugants.
Mating experiment controlsfor transformation and transduction
Transformation. Donor and recipient cultures were grown to log phase and mixed for mating in the presence of DNase I (10 ,Lg/ml) and MgSO4 (5 mM) (12) . These mating mixtures and controls were incubated for only 4 [1.2 ,umol of DNA nucleotide/ml) and water (120 1ul), followed by 10% TCA (0.5 ml) and held at 0°C for 10 min (Carrier DNA was diluted to 1.2 mM with the molar extinction coefficient, 6.9 mM at 260 j,m). After the addition of 3.0 ml of chilled 1.0 N HCI, the mixture was pipetted onto prewetted (1. 0 N HCI) glass fiber filter paper disks (Whatman GF/C, Whatman, Inc., Clifton, N. J., W and R Balston, Ltd., England), flushed twice with 3.0 ml of chilled HCI and washed with 80 ml of HCI, before the addition of absolute ethanol (5.0 ml). Disks were then dried and counted in Omnifluor (New England Nuclear, Boston, Mass.)/toluene. Controls included tubes without [3H]DNA and without DNase 1. To evaluate the effect of DNase I on transfer of resistance, selective media were again employed to calculate the number of donor, recipient, and transconjugant organisms per milliliter, and thus the frequency of transfer.
Transduction
The supernate of a mid-log phase donor culture was filtered after centrifugation at 4,500 g for 15 min at 4°C and mixed with a mid-log phase culture of the recipient strain. In addition, donor cultures in mid-log phase were treated with chloroform (0.2 ml in 10 ml) and the filtrate, after shaking for 2 h at 37°C to remove the chloroform and after passage through a 0.45-jsm Millipore filter (Millipore Corp.) to remove viable bacteria, was mixed with a mid-log phase culture of the recipient strain (12) . Evidence of bacteriophage plaque production was sought by placing several drops of donor cultures on plain BHI plates overlaid with soft agar (0.8%) containing the recipient strain, JH2-7. The supernates of donor cultures were tested after centrifugation, after filtration, and after chloroform treatment (12) .
Cesium chloride-ethidium bromide ultracentrifugation
Two methods were used. The first was that of Jacob and Hobbs (12) with several modifications. Late-log phase cells from 100 ml of liquid BHI were harvested by centrifugation at 4500 g for 15 min at 4°C. The cells were resuspended and washed twice in 5.0 ml of 50 mM Tris, 5 mM Na2EDTA, 50 mM NaCl, pH 8.0 (TES). Final resuspension was in 1.25 ml of TES/10% sucrose (wt/vol). Then 1.25 ml of TES/10% sucrose containing 2 mg of lysozyme and 1 mg of RNase A (not heat inactivated) per ml was added and the mixture was incubated at 37°C for 2 h. Lysis was accomplished by the addition of 1.25 ml of N-lauroylsarcosine (Sigma Chemical Co., 2.4% wt/vol in distilled water). After the further addition of 2.5 ml of TES, the lysate was sheared by drawing it in and out of a 5.0-ml serological pipette 20 times. Individual gradient tubes contained 6.91 g of CsCl (optical quality, Calbiochem), 4.5 ml of TES, 1.5 ml of TES with 1.5 mg/ml of ethidium bromide (Calbiochem), and 1.725 ml of sheared lysate. After mixing, the refractive index of gradients varied from 1.386 to 1.387.
The second method employed for preparation of cesium chloride-ethidium bromide gradients was a modification ofthe procedure of Palchaudhuri and Chakrabarty (15) . A 500-ml culture in liquid BHI was grown to late-log phase and harvested as described above. Cells were resuspended in 12.5 ml of Tris (0.05 M, pH 8.0)/25% sucrose (wt/wt) and frozen overnight. The following morning, they were thawed rapidly in a 37°C water bath and 1.25 ml of lysozyme (40 mg/ml in 0.25 M Tris, pH 8.0) and 1.25 ml of Na2EDTA (0.25 M, pH 8.0) were added to each tube. The contents were mixed by inversion and incubated at 37°C for 2 h. Lysis was then accomplished by the addition of 12.5 ml of Nlauroylsarcosine (2% in 0.05 M Tris, pH 8.0 -1.5 M NaCl) which had been prewarmed to 37°C. Some strains required additional N-lauroylsarcosine for lysis (1-2 ml of a 20% solution in water). After an additional 15-30 min at 37°C, the lysates were sheared by five passages through a 35-ml glass syringe without a needle. They were then held on ice at 0°C until alkali treatment. The pH of each lysate was raised to 12.1-12.2 with NaOH (4.0 N) at room temperature, waiting [10] [11] [12] [13] [14] [15] s after each addition of alkali to permit equilibration of the viscous lysate with stirring. A total of 2-4 ml of NaOH was usually required. After waiting at least a minute with the pH at 12.1-12.2, Tris (2.0 M, pH 5.0) was added until the pH again reached 8.0; this usually required 25-35 ml. As soon as the pH had returned to 8.0, 12.5 g of nitrocellulose (kindly provided by Hercules, Inc., Wilmington, Del., RS 0.5 s) was added to the lysate and stirring was continued at 40 C for another 45 min. (Before use, the nitrocellulose had been washed four times with a liter of 0.3 M NaCl-0.03 M Na citrate solution, and allowed to dry in the air without exposure to heat). After stirring, the nitrocellulose was allowed to sediment. The cloudy supernate was decanted and centrifuged at 2,500 g for 10 min at 40C to remove additional nitrocellulose. The resulting supernate was carefully layered onto a 2.5-ml cushion of TES containing CsCl (61.7% wt/wt) and centrifuged for 14 h in a type 30 rotor at 14,000 rpm (17,000g) with a Beckman model L ultracentrifuge (Beckman Instruments, Inc., Spinco Division, Palo Alto, Calif.) at 8°C.
After centrifugation, all but the bottom 10 ml was removed from each tube; the pellet was homogenized with a glass stirring rod and the suspension was filtered through glass wool to remove residual nitrocellulose. The ref'ractive index of the filtrate was adjusted to 1.400 by the addition of' -5.7 g of CsCl. Before isopyonic ultracentrifugation, 0.2 ml of Tris (0.05 M, pH 8.0) containing ethidium bromide (5 mg/ml) was added to each tube. Gradients were centrifuged at 33,000 rpm (72,000 g) for 40 h in a Beckman model L ultracentrifuge at 8°C with a type 40 rotor. After centrifugation, satellite bands were identified with the aid of a long wave ultra-violet lamp (Chromato-Vue Transilluminator, model C-62, Ultra-Violet Products, Inc., San Gabriel, Calif.) and removed with a fractioning device. Ethidium bromide was removed by two extractions with equal volumes of cesium chloride-saturated isopropanol. Cesium chloride was removed by dialysis against TES, allowing 1-2 h for the first change, and 4-6 h f'or the second, at 4°C.
Agarose gel electrophoresis of DNA The method of Meyers et al. (16) was used with several minor modifications. Crude lysates were treated (final concentration of 200 ,ug pronase per ml) f'or 30 min at 37°C rather than extracted with phenol. The E buffer of Sharp et al. (17) was used rather than a Tris-borate buffer, and 1.0% agarose (Sigma Chemical Co.) was employed for the vertical slab gel. A short-wave ultraviolet light source (ChromatoVue Transilluminator, model C-61, Ultra-Violet Products, Inc.) was used to photograph gels after ethidium bromide staining.
Electron microscopy of plasmid DNA Satellite bands removed from CsCl-ethidium bromide gradients for study by electron microscopy were dialyzed against 0.05 M Tris, 0.002 M Na2EDTA, pH 8.5, to remove CsCl after extraction with isopropanol. Plasmid DNA obtained from the satellite band of Escherichia coli strain JC 411 containing the plasmid ColEl (wt, 4.2 megadaltons) (18) was incorporated in DNA preparations to provide an internal marker for measuring the size of the enterococcal plasmid. Grids coated with 3.5% parlodion were used to pick up DNA spread onto the aqueous 0.25 M ammonium acetate hypophase (19) . They were stained in 10 ml of 90% ethanol (vol/vol) containing uranyl acetate (100 ,ul of a 50 mM solution in glass-distilled water) for 30 s, and rinsed in 90% ethanol for another 30 s before being allowed to dry (20) . Grids were shadowed with platinum-palladium by a JEOL vacuum shadower (JEOL Analytical Instruments, Cranford, N. J., model JEE-4C). They were examined and photographed with RCA 3G and Philips 200 electron microscopes (RCA Solid State, Somerville, N. J. and Philips Electronic Instruments, Inc., Mahwah, N. J.).
Measurements of plasmid size were obtained by tracing projected images of plasmids f'rom electron photomicrographs with an electronic graphics calculator in the length mode (model 250-117, Numonics Corp., Lansdale, Pa.) and comparing the size (length) of the enterococcal plasmid with ColEl. Three measurements were made of each plasmid to obtain an average. Established statistical methods were used to calculate the standard deviation (21) .
Synergism experiments
These were performed according to the protocol of' Moellering et al. (9) . Synergism was defined as a 100-fold (2 (14) . Single colonies were again isolated on BHI agar and retested to confirm their antibiotic resistance pattern before they were examined by cesium chloride-ethidium bromide ultracentrifugation or used in antibiotic synergism studies.
RESULTS
Mating experiments
Three resistant clinical isolates were studied and found to transfer high-level streptomycin and kanamycin resistance to-the sensitive recipient, JH2-7 (Table I) .
Mating experiment controlsfor transformation and transduction
Transformation. Treatment of donor and recipient cultures and the mating mixture with DNase I and MgSO4 did not reduce the frequency of transfer observed.
[3H]DNA assay of DNase I activity. After demonstrating the activity of DNase I in distilled water and Electron microscopy Although circular molecules of similar size were observed in plasmid DNA preparations from strain EBC-22 (pDR 1), detailed measurements were made only on electron photomicrographs of the satellite band obtained from the transconjugant strain (JH2-7 [pDR 1]) (Fig. 2) . 11 circular molecules were measured. Based upon the relative length of the ColEl molecule (4.2 megadaltons) (18) , the size of the enterococcal plasmid was calculated to be 45 megadaltons (44.8 +2.8, mean±SD (21) ).
Synergism studies
The clinical isolate, EBC-22 (pDR 1), with highlevel resistance to streptomycin and kanamycin, was also resistant to penicillin-streptomycin and penicillinkanamycin synergism (Fig. 3) . The recipient strain, JH2-7, which was sensitive to high-level streptomycin and kanamycin, was also sensitive to penicillin-aminoglycoside synergism (Fig. 4) . However, the transconjugant strain JH2-7 (pDR 1), which acquired highlevel resistance to streptomycin and kanamycin after mating, also acquired resistance to penicillin-aminoglycoside synergism with those two aminoglycosides (Fig. 5) . Nine additional transconjugant strains from the EBC-22/JH2-7 cross, and 10 from the EBC-15/JH2-7 cross have been studied and found resistant to both penicillin-streptomycin and penicillin-kanamycin synergism. Thus, a total of 20 transconjugant strains with high-level aminoglycoside resistance have all demonstrated resistance to antibiotic synergism. Because DNase I treatment did not reduce the frequency of transfer, and cell-free filtrates failed to transfer the resistance markers, the most likely mechanism of the transfer we have observed is conjugation, rather than transformation or transduction. These findings are also similar to the earlier work of Jacob and Hobbs (12) .
Why the frequency of transfer observed with these strains varies over such a wide range (3 x 10-2 to 6.9 X 10-7) is not clear. Although transfer frequencies approaching 100% have been reported among gramnegative bacteria (24) , the upper end ofthe range found here (3 x 10-2) may be the highest described to date among gram-positive organisms. Because the recipient strain, JH2-7, which is sensitive to antibiotic synergism, acquired resistance to penicillin-streptomycin and penicillin-kanamycin synergism after acquisition of a plasmid from a resistant clinical isolate, these results suggest that gene(s) involved in resistance to penicillin-aminoglycoside synergism are present on that plasmid, and that they may be the same gene(s) responsible for high-level resistance to strept6mycin and kanamycin.
Several lines of evidence from physical studies, including cesium chloride-ethidium bromide ultracentrifugation, agarose gel electrophoresis, and electron microscopy, corroborate the association of the 45-megadalton plasmid with both high-level resistance to streptomycin and kanamycin, and resistance to penicillin-streptomycin and penicillin-kanamycin synergism. Although smaller plasmids (3-8 megadaltons) were present in several erythromycin-resistant clinical isolates, the 45-megadalton plasmid was the only one consistently present in strains with high-level resistance to streptomycin and kanamycin. In addition, acquisition of the 45-megadalton plasmid (without the smaller plasmid) by the sensitive recipient strain coincided with acquisition of both high-level aminoglycoside resistance and resistance to penicillinaminoglycoside synergism, whereas loss ofthe plasmid or a reduction in its size (after novobiocin treatment) coincided with loss of both these traits. Although examination of several other clinical enterococcal isolates with high-level aminoglycoside resistance by agarose gel electrophoresis (after cesium chlorideethidium bromide ultra-centrifugation) revealed a plasmid of similar size, we do not have enough information to generalize about plasmids in S. faecalis clinical isolates with high-level aminoglycoside resistance.
It is not yet clear why isolation of this plasmid appears to require either RNase treatment before lysis or alkali treatment after lysis. Although we have no direct evidence for their presence, one possible explanation would be RNA linkages between plasmid and chromosomal DNA, as have been suggested in E. coli (25) . Another potential explanation would be DNA-DNA interactions between the chromosome and plasmid. Although alkali treatment denatures both DNA and RNA (26) , RNase treatment was effective with or without heat inactivation. Therefore, these results are most consistent with RNA linkages between the plasmid and chromosome.
Novobiocin is known to interfere in vitro with the activity of DNA gyrase from E. coli (27) , and novobiocin treatment has been shown to eliminate plasmids from a variety of bacterial hosts (22) . Therefore, 10 single-colony isolates which had lost high-level aminoglycoside resistance after novobiocin treatment of a resistant clinical strain were examined by cesium chloride-ethidium bromide ultracentrifugation. Although a plasmid band was still present in 1 of the 10 isolates, the plasmid was reduced in size when examined by agarose gel electrophoresis. These results suggest that, on occasion, novobiocin treatment may induce or select for deletion of plasmid genes. Both patterns observed after novobiocin treatment (i.e., loss of the entire plasmid or a significant reduction in its size) are compatible with the loss of genes related to aminoglycoside resistance and resistance to antibiotic synergism.
The simultaneous loss of both high-level resistance and resistance to synergism suggests that the genes controlling these traits are on the same plasmid. It does not establish whether they are identical or merely linked.
Our present hypothesis is that the gene(s) responsible for high-level resistance to aminoglycosides are also responsible for resistance to antibiotic synergism with penicillin and that aminoglycoside in enterococci. These studies clearly relate high-level aminoglycoside resistance and resistance to antibiotic synergism among some clinical isolates of enterococci to the presence of a transferable 45 megadalton plasmid. We suggest that the prevalence of highlevel aminoglycoside resistance and resistance to antibiotic synergism currently observed in many other centers, may also be plasmid mediated.
